Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

The company was founded in 1990, has four production bases of “Tonghua Jinma Pharmaceutical, Harbin Shengtai Pharmaceutical, Chengdu Yongkang Pharmaceutical, and Henan Yuanshou Pharmaceutical”, and has three new pharmaceutical research institutes “Changchun Huayang, Beijing Minkang Baicao, and Shanghai Shijian”. It is a modern pharmaceutical enterprise group integrating R&D, production and sales. The company is mainly engaged in R&D, production and sales of pharmaceutical products. The leading products mainly include compound Lactobacillus acidophilus tablets, rheumatism pain relief capsules, liver and spleen cleansing oral solution, and Qinshih throat oral solution. Corporate honors: “Innovative Technology Enterprise” issued by the Jilin Provincial Department of Science and Technology and the Jilin Provincial Department of Finance in 2013; “Model Tax Payment Enterprise” issued by the Erdaojiang District Committee of China and the People's Government of Erdaojiang District of Tonghua City in 2013; “Top 100 Traditional Chinese Medicine Industry Enterprises” issued by the 2011 Chinese Medicine Industry Annual Summit; won the “Top 100 Chinese Medicine Brand Enterprises” in 2023. In 2019, the company was rated as a “Top 100 Chinese Pharmaceutical Manufacturers”, and in 2019, the company was rated as a “Top 100 Chinese Medicine Brand Enterprise” ” and other titles.